What’s the Difference Between ‘Good and Evil’ in Cell Culture Media?
| MVDA-Omics Methods Provide the Answers!
The industrial cultivation of cell cultures is the backbone of many products from the biopharmaceutical sector. Processes, cells, and media are highly optimized, and cultivations are routinely performed in large-scale bioreactors. However, the path a process must take to end up in a routine pharmaceutical reactor is long and bumpy. Right now, through the emergence of cell and gene therapies, we have the unique opportunity to showcase how omics techniques and multivariate data analysis (MVDA) can be applied in an industrial context to facilitate pharmaceutical developments.
In this webinar, we will delve into the transformative potential of metabolomics and MVDA in the biopharmaceutical industry, with a focus on two pivotal examples: Adeno-Associated Virus (AAV) and stem cells. These projects represent two essential parts of advanced therapies.
AAV will be highlighted as a prime example of how process and media development can be elevated through advanced analytical techniques. By leveraging omics and MVDA, we can help optimize production processes, enhance yield, and ensure the consistency and quality of biopharmaceutical products.
Stem cells, on the other hand, will be explored as a case study in root cause analysis. Through the application of MVDA, we can uncover the underlying factors affecting established processes, leading to improved efficiency and reliability in stem cell cultivation.
What You Will Learn:
- How can metabolomics techniques be applied in industrial settings
- How does MVDA help during industrial process development
- Where root-cause analysis through untargeted analytics helps in routine processes